Label: CENTIPAINE FOR PAIN CONTROL- lidocaine 4%, menthol 1% patch

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated October 20, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Active Ingredients

    Lidocaine 4%

    Menthol 1%

  • PURPOSE

    Purpose

    Topical Analgesic

  • INDICATIONS & USAGE

    Uses

    For the temporary relief of pain.

  • WARNINGS

    Warnings

    For external use only not intended for ingestion.

  • DO NOT USE

    Do not use

    • in large quantities, particularly over raw surfaces, or blistered areas.
  • WHEN USING

    When using this product

    • Avoid contact with the eyes.
  • ASK DOCTOR

    Stop use and ask doctor if

    • condition worsens, or if symtoms persist for more than 7 days or clear up and occur again within a few days.
  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children.

    If swallowed, get medical help, or contact a Poison Control Central right away.

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use.

  • DOSAGE & ADMINISTRATION

    Directions

    • Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times a daily.
    • Children under 2 years of age: consult a doctor.
  • OTHER SAFETY INFORMATION

    Other Information

    Store at 20-25 oC (68-77 oF) and protect from moisture.

  • INACTIVE INGREDIENT

    Inactive ingredients

    polyacrylamide, vinol, sodium polyacrylate; acrylate polymerization, purified water.

  • QUESTIONS

    Questions?

    (310) 320-0100

  • PRINCIPAL DISPLAY PANEL

    box

  • INGREDIENTS AND APPEARANCE
    CENTIPAINE FOR PAIN CONTROL 
    lidocaine 4%, menthol 1% patch
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:76420-146
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A) (MENTHOL, UNSPECIFIED FORM - UNII:L7T10EIP3A) MENTHOL, UNSPECIFIED FORM1 g  in 100 g
    LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE4 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    POLYACRYLAMIDE (10000 MW) (UNII: E2KR9C9V2I)  
    ETHENYL (UNII: PQ2K3G3591)  
    ACRYLATES CROSSPOLYMER-6 (UNII: 4GXD0Q3OS3)  
    SODIUM POLYACRYLATE (2500000 MW) (UNII: 05I15JNI2J)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:76420-146-033 in 1 BOX01/19/2022
    14 g in 1 PATCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph Drug505G(a)(3)12/23/2021
    Labeler - ASCLEMED USA INC. (059888437)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!